Neo Ivy Capital Management »

Kymera Therapeutics shares owned by Neo Ivy Capital Management

Quarter-by-quarter ownership of Kymera Therapeutics (KYMR) shares owned by Neo Ivy Capital Management from 13F filings

Historical chart of Neo Ivy Capital Management investment in Kymera Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Kymera Therapeutics held by Neo Ivy Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Kymera Therapeutics by Neo Ivy Capital Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $1.1M 20k 56.60
2025-06-30 $895k 21k 43.64
2025-03-31 $395k 14k 27.37

More positions owned by Neo Ivy Capital Management

NVIDIA Corporation (NVDA)
Ford Motor Company (F)
Centene Corporation (CNC)
Ceridian Hcm Hldg (DAY)
Comcast Corp-a Cl A (CMCSA)
Palantir Techn-a Cl A (PLTR)
Southern Company (SO)
Hanesbrands (HBI)
Pitney Bowes (PBI)
Confluent Inc-a Class A Com (CFLT)
Cadence Bank (CADE)
Unity Software (U)
UnitedHealth (UNH)
At&t (T)
Hims & Hers Heal Com Cl A (HIMS)

View all positions for Neo Ivy Capital Management

Top funds holding Kymera Therapeutics

Baker Bros. Advisors
venBio Select Advisor
Vanguard Group
FMR
BVF
Wellington Management Company
Atlas Venture Life Science Advisors
BlackRock
Siren
State Street Corporation
Geode Capital Management
Capital Research Global Investors
Driehaus Capital Management
Ubs Global Asset Management Americas
Holocene Advisors

View all funds holding Kymera Therapeutics